Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G‐Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease

Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G‐Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease

Background Patients with nonalcoholic fatty liver disease are at increased risk to develop atherosclerotic cardiovascular diseases. FXR and GPBAR1 are 2 bile acid–activated receptors exploited in the treatment of nonalcoholic fatty liver disease: whether dual GPBAR1/FXR agonists synergize with stati...

Full description

Bibliographic Details
Main Authors: Silvia Marchianò, Michele Biagioli, Martina Bordoni, Elva Morretta, Cristina Di Giorgio, Valentina Vellecco, Rosalinda Roselli, Rachele Bellini, Carmen Massa, Luigi Cari, Ginevra Urbani, Patrizia Ricci, Maria Chiara Monti, Antonino Giordano, Vincenzo Brancaleone, Mariarosaria Bucci, Angela Zampella, Eleonora Distrutti, Enrico Cieri, Giuseppe Cirino, Stefano Fiorucci
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
bile acid signaling
cardiovascular diseases
farnesoid X receptor
G‐protein bile acid receptor 1
nonalcoholic steatohepatitis
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.031241

Similar Items

Similar Items